Myasthenia gravis (MG) is a rare, chronic autoimmune disease with symptoms of fluctuating
muscular weakness and fatigability. The aim of this retrospective cohort study was to …

Introduction Myasthenia gravis (MG) is a rare neuromuscular disorder marked by a variable
combination of weakness of eye, bulbar, respiratory, axial, and limb muscles. This study …

The terminal complement C5 inhibitor ravulizumab was engineered from the humanized
monoclonal antibody eculizumab to have an extended half-life and duration of action. It …

Background Patients with myasthenia gravis (MG) lose part of their working or living ability
due to illness, and bring burden to caregivers. The purpose of this study was to explore the …

Background Regular and consistent disease assessment could provide a clearer picture of
burden in generalised myasthenia gravis (gMG) and improve patient care; however, the use …

Fatigue is commonly associated with myasthenia gravis (MG), but factors contributing to
fatigue development in MG are incompletely understood. This nationwide cross-sectional …

Myasthenia gravis (MG) is a serious and debilitating autoimmune disease characterized by
muscle weakness, shortness of breath, and issues affecting the eyes, limbs, throat, and …

Results: Of the 2062 posts observed (N= 2062), 1392 featured questions (n= 1392).
Questions were asked by 787 unique users: 531 were identified as one-time users (67%) …

CONFIDENTIAL UNTIL PUBLISHED Page 1 CONFIDENTIAL UNTIL PUBLISHED External
Assessment Group Report commissioned by the NIHR Evidence Synthesis Programme on …

Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by
muscle weakness and fatigue, which can significantly impact various facets of daily life …